[1]
“A Prospective Study On Rifaximin’s Activity And Immunomodulatory Impact In Prophylaxis Of Spontaneous Bacterial Peritonitis In Cirrhotic Pakistani Population”, Journal of Pharmaceutical Negative Results, pp. 3879–3885, May 2023, doi: 10.47750/pnr.2023.14.03.485.